Grant M. Fischer

Dermatology
75 Francis St
Boston, MA 2115.

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 30 publications

Undifferentiated Melanoma: A Clinicopathologic and Gene Expression Analysis Study With Identification of HMGA2 as a Diagnostic Marker.

Undifferentiated Melanoma: A Clinicopathologic and Gene Expression Analysis Study With Identification of HMGA2 as a Diagnostic Marker.

Journal: The American journal of surgical pathology
Published: July 10, 2025

Loss of ten-eleven translocation 2 (TET2) facilitates aggressive behaviour in cutaneous melanoma by inducing peroxisome proliferator-activated receptor-γ coactivator 1α expression and oxidative phosphorylation.

Loss of ten-eleven translocation 2 (TET2) facilitates aggressive behaviour in cutaneous melanoma by inducing peroxisome proliferator-activated receptor-γ coactivator 1α expression and oxidative phosphorylation.

Journal: The British journal of dermatology
Published: June 17, 2025

Genomic Profiling of Pediatric Mycosis Fungoides, Lymphomatoid Papulosis, and Primary Cutaneous Anaplastic Large Cell Lymphoma Identifies Recurrent Tyrosine Kinase Gene Fusions.

Genomic Profiling of Pediatric Mycosis Fungoides, Lymphomatoid Papulosis, and Primary Cutaneous Anaplastic Large Cell Lymphoma Identifies Recurrent Tyrosine Kinase Gene Fusions.

Journal: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
Published: June 11, 2025

Oxidative Phosphorylation (OXPHOS) Promotes the Formation and Growth of Melanoma Lung and Brain Metastases.

Oxidative Phosphorylation (OXPHOS) Promotes the Formation and Growth of Melanoma Lung and Brain Metastases.

Journal: bioRxiv : the preprint server for biology
Published: February 03, 2025

High-grade sarcoma arising within a cellular dermatofibroma.

High-grade sarcoma arising within a cellular dermatofibroma.

Journal: JAAD case reports
Published: January 22, 2025

Pembrolizumab-induced Stevens-Johnson syndrome-like reaction: An atypical clinical presentation.

Pembrolizumab-induced Stevens-Johnson syndrome-like reaction: An atypical clinical presentation.

Journal: JAAD case reports
Published: December 10, 2024

Integrated analysis of molecular and clinical features associated with overall survival in melanoma patients with brain metastasis.

Integrated analysis of molecular and clinical features associated with overall survival in melanoma patients with brain metastasis.

Journal: Acta neuropathologica communications
Published: November 24, 2024

Preclinical models of melanoma leptomeningeal disease to assess intrathecal checkpoint blockade.

Preclinical models of melanoma leptomeningeal disease to assess intrathecal checkpoint blockade.

Journal: Scientific reports
Published: October 22, 2024

PRAME Expression in Melanoma is Negatively Regulated by TET2-Mediated DNA Hydroxymethylation.

PRAME Expression in Melanoma is Negatively Regulated by TET2-Mediated DNA Hydroxymethylation.

Journal: Laboratory investigation; a journal of technical methods and pathology
Published: October 15, 2024

PRAME expression in melanoma is negatively regulated by TET2-mediated DNA hydroxymethylation.

PRAME expression in melanoma is negatively regulated by TET2-mediated DNA hydroxymethylation.

Journal: bioRxiv : the preprint server for biology
Published: August 02, 2024

Author Correction: Concurrent intrathecal and intravenous nivolumab in leptomeningeal disease: phase 1 trial interim results.

Author Correction: Concurrent intrathecal and intravenous nivolumab in leptomeningeal disease: phase 1 trial interim results.

Journal: Nature medicine
Published: April 22, 2024

A Comparative Genomic Study of Conventional and Undifferentiated Melanoma.

A Comparative Genomic Study of Conventional and Undifferentiated Melanoma.

Journal: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
Published: March 04, 2024
Showing 1-12 of 30

Last Updated: 09/26/2026